SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-295663
Filing Date
2011-11-04
Accepted
2011-11-03 20:03:03
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d242260d10q.htm 10-Q 512996
2 CERTIFICATION OF PEO REQUIRED BY RULE 13A-14(A) d242260dex311.htm EX-31.1 9572
3 CERTIFICATION OF PFO REQUIRED BY RULE 13A-14(A) d242260dex312.htm EX-31.2 9442
4 SECTION 1350 CERTIFICATIONS d242260dex321.htm EX-32.1 4732
  Complete submission text file 0001193125-11-295663.txt   3185916

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20110930.xml EX-101.INS 461216
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20110930.xsd EX-101.SCH 33250
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20110930_cal.xml EX-101.CAL 46808
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20110930_def.xml EX-101.DEF 71256
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20110930_lab.xml EX-101.LAB 223159
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20110930_pre.xml EX-101.PRE 162234
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 111179057
SIC: 2834 Pharmaceutical Preparations